Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Kidney International|March 7, 2001
Gentamicin causes endocytosis of Na/Pi cotransporter protein (NaPi-2)V Sorribas, N Halaihel, K Puttaparthi, et al.
The Journal of Antimicrobial Chemotherapy|August 23, 2007
Impact of steady-state lopinavir plasma levels on plasma lipids and body composition after 24 weeks of lopinavir/ritonavir-containing therapy free of thymidine analoguesA León, E Martinez, M Sarasa, et al.
Neuroscience|January 23, 2014
Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's diseaseM Izco, P Martínez, A Corrales, et al.
Neuroscience|July 26, 2005
The chick embryo appears as a natural model for research in beta-amyloid precursor protein processingJ A Carrodeguas, A Rodolosse, M V Garza, et al.
The Journal of Prevention of Alzheimer'S Disease|December 21, 2018
Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 StudyV Pérez-Grijalba, J Romero, P Pesini, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2009
Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureusJ M Miró, C García-de-la-Mària, Y Armero, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Dose-finding study of once-daily indinavir/ritonavir plus zidovudine and lamivudine in HIV-infected patientsJ Mallolas, J L Blanco, M Sarasa, et al.
HIV Medicine|April 28, 2007
Inhibitory quotient as a prognostic factor of response to a salvage antiretroviral therapy containing ritonavir-boosted saquinavir. The CIVSA StudyJ Mallolas, Jl Blanco, P Labarga, et al.
The Journal of Prevention of Alzheimer'S Disease|November 30, 2017
FACEHBI: A Prospective Study of Risk Factors, Biomarkers and Cognition in a Cohort of Individuals with Subjective Cognitive Decline. Study Rationale and Research ProtocolsO Rodriguez-Gomez, A Sanabria, A Perez-Cordon, et al.
Alzheimer'S Research & Therapy|December 1, 2018
Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI)Itziar de Rojas, J Romero, O Rodríguez-Gomez, et al.
Pageof 5